Skip to main content
Top
Published in: BMC Medical Imaging 1/2020

01-12-2020 | Ultrasound | Case report

Application of contrast-enhanced ultrasonography for large cell neuroendocrine carcinoma in the urinary bladder: a case report

Authors: Wei Li, Ze-Zhen Su, Ji-Hui Kang, Xiao-Yan Xie, Xiao-Hua Xie, Bo-Wen Zhuang

Published in: BMC Medical Imaging | Issue 1/2020

Login to get access

Abstract

Background

Large cell neuroendocrine carcinoma (LCNEC) of the urinary bladder is an uncommon malignant bladder tumor, and the overall prognosis is poor. Contrast-enhanced ultrasound (CEUS) provides a new effective modality for tumor detection and diagnosis.

Case presentation

A 30-year-old man complained of repeated painless gross haematuria for half a month. Conventional ultrasound demonstrated a hypoechoic solitary lesion with hyperechoic margins measuring 3.4 × 3.1 cm in the anterior wall of the bladder. Superb microvascular imaging (SMI) showed a strong flow signal in the mass. CEUS revealed that the lesion was characterized by hyper-enhancement in the early phase and hypo-enhancement in the late phase. The entire bladder wall was disrupted by homogeneous hyper-enhanced tumor tissue on CEUS. Time-intensity curves (TICs) showed a rapid wash-in with a high maximum signal intensity (SI) and quick wash-out. Finally, partial cystectomy was performed and the pathological examination confirmed the diagnosis of LCNEC with invasion into the whole layer of the bladder wall.

Conclusion

This case suggested that CEUS was a valuable imaging method to detect and diagnose LCNEC in the bladder, and that CEUS can provide information related to the depth of wall invasion and the microvasculature.
Literature
1.
go back to reference Radović N, Turner R, Bacalja J. Primary “pure” large cell neuroendocrine carcinoma of the urinary bladder: a case report and review of the literature. Clin Genitourin Canc. 2015;13(5):e375–7.CrossRef Radović N, Turner R, Bacalja J. Primary “pure” large cell neuroendocrine carcinoma of the urinary bladder: a case report and review of the literature. Clin Genitourin Canc. 2015;13(5):e375–7.CrossRef
2.
go back to reference Acosta AM, Kajdacsy-Balla A. Primary neuroendocrine tumors of the ureter: a short review. Arch Pathol Lab Med. 2016;140(7):714–7.CrossRef Acosta AM, Kajdacsy-Balla A. Primary neuroendocrine tumors of the ureter: a short review. Arch Pathol Lab Med. 2016;140(7):714–7.CrossRef
3.
go back to reference Abenoza P, Manivel C, Sibley RK. Adenocarcinoma with neuroendocrine differentiation of the urinary bladder. Clinicopathologic, immunohistochemical, and ultrastructural study. Arch Pathol Lab Med. 1986;110(11):1062–6.PubMed Abenoza P, Manivel C, Sibley RK. Adenocarcinoma with neuroendocrine differentiation of the urinary bladder. Clinicopathologic, immunohistochemical, and ultrastructural study. Arch Pathol Lab Med. 1986;110(11):1062–6.PubMed
4.
go back to reference Coelho HMP, Pereira BAGJ, Temido PASC. Large cell neuroendocrine carcinoma of the urinary bladder: case report and review. Curr Urol. 2013;7(3):155–9.CrossRef Coelho HMP, Pereira BAGJ, Temido PASC. Large cell neuroendocrine carcinoma of the urinary bladder: case report and review. Curr Urol. 2013;7(3):155–9.CrossRef
5.
go back to reference Boyer AC, Jafri SZ, Jafri SMA, Amin MB. Neuroendocrine carcinoma of the urinary bladder: a retrospective study of CT findings. Abdom Imaging. 2013;38(4):870–6.CrossRef Boyer AC, Jafri SZ, Jafri SMA, Amin MB. Neuroendocrine carcinoma of the urinary bladder: a retrospective study of CT findings. Abdom Imaging. 2013;38(4):870–6.CrossRef
6.
go back to reference Sari A, Ermete M, Sadullahoglu C, Bal K, Bolukbasi A. Large cell neuroendocrine carcinoma of urinary bladder; case presentation. Turkish J Pathol. 2013;29(2):138.CrossRef Sari A, Ermete M, Sadullahoglu C, Bal K, Bolukbasi A. Large cell neuroendocrine carcinoma of urinary bladder; case presentation. Turkish J Pathol. 2013;29(2):138.CrossRef
7.
go back to reference Caruso G, Salvaggio G, Campisi A, Melloni D, Midiri M, Bertolotto M, et al. Bladder tumor staging: comparison of contrast-enhanced and gray-scale ultrasound. AJR Am J Roentgenol. 2010;194(1):151–6.CrossRef Caruso G, Salvaggio G, Campisi A, Melloni D, Midiri M, Bertolotto M, et al. Bladder tumor staging: comparison of contrast-enhanced and gray-scale ultrasound. AJR Am J Roentgenol. 2010;194(1):151–6.CrossRef
8.
go back to reference Drudi FM, Cantisani V, Liberatore M, Iori F, Erturk SM, Cristini C, et al. Role of low-mechanical index CEUS in the differentiation between low and high grade bladder carcinoma: a pilot study. Ultraschall Med. 2010;31(6):589–95.CrossRef Drudi FM, Cantisani V, Liberatore M, Iori F, Erturk SM, Cristini C, et al. Role of low-mechanical index CEUS in the differentiation between low and high grade bladder carcinoma: a pilot study. Ultraschall Med. 2010;31(6):589–95.CrossRef
9.
go back to reference Nicolau C, Bunesch L, Peri L, Salvador R, Corral JM, Mallofre C, Sebastia C. Accuracy of contrast-enhanced ultrasound in the detection of bladder cancer. Br J Radiol. 2011;84(1008):1091–9.CrossRef Nicolau C, Bunesch L, Peri L, Salvador R, Corral JM, Mallofre C, Sebastia C. Accuracy of contrast-enhanced ultrasound in the detection of bladder cancer. Br J Radiol. 2011;84(1008):1091–9.CrossRef
10.
go back to reference Guo SP, Xu P, Zhou AY, Wang GX, Chen WM, Mei JH, et al. Contrast-enhanced ultrasound differentiation between low- and high- grade bladder urothelial carcinoma and correlation with tumor microvessel density. J Ultrasound Med. 2017;36(11):2287–97.CrossRef Guo SP, Xu P, Zhou AY, Wang GX, Chen WM, Mei JH, et al. Contrast-enhanced ultrasound differentiation between low- and high- grade bladder urothelial carcinoma and correlation with tumor microvessel density. J Ultrasound Med. 2017;36(11):2287–97.CrossRef
11.
go back to reference Bhatt VR, Loberiza FJ, Tandra P, Krishnamurthy J, Shrestha R, Wang J. Risk factors, therapy and survival outcomes of small cell and large cell neuroendocrine carcinoma of urinary bladder. Rare Tumors. 2014;6(1):5043.CrossRef Bhatt VR, Loberiza FJ, Tandra P, Krishnamurthy J, Shrestha R, Wang J. Risk factors, therapy and survival outcomes of small cell and large cell neuroendocrine carcinoma of urinary bladder. Rare Tumors. 2014;6(1):5043.CrossRef
12.
go back to reference Nicolau C, Bunesch L, Sebastia C, Salvador R. Diagnosis of bladder cancer: contrast-enhanced ultrasound. Abdom Imaging. 2010;35(4):494–503.CrossRef Nicolau C, Bunesch L, Sebastia C, Salvador R. Diagnosis of bladder cancer: contrast-enhanced ultrasound. Abdom Imaging. 2010;35(4):494–503.CrossRef
13.
go back to reference Gakis G, Witjes JA, Compérat E, Cowan NC, De SM, Lebret T, et al. European Association of Urology. EAU guidelines on primary urethral carcinoma. Eur Urol. 2013;64(5):823–30.CrossRef Gakis G, Witjes JA, Compérat E, Cowan NC, De SM, Lebret T, et al. European Association of Urology. EAU guidelines on primary urethral carcinoma. Eur Urol. 2013;64(5):823–30.CrossRef
14.
go back to reference Macrì F, Di Pietro S, Mangano C, Pugliese M, Mazzullo G, Iannelli NM, et al. Quantitative evaluation of canine urinary bladder transitional cell carcinoma using contrast-enhanced ultrasonography. BMC Vet Res. 2018;14(1):84.CrossRef Macrì F, Di Pietro S, Mangano C, Pugliese M, Mazzullo G, Iannelli NM, et al. Quantitative evaluation of canine urinary bladder transitional cell carcinoma using contrast-enhanced ultrasonography. BMC Vet Res. 2018;14(1):84.CrossRef
Metadata
Title
Application of contrast-enhanced ultrasonography for large cell neuroendocrine carcinoma in the urinary bladder: a case report
Authors
Wei Li
Ze-Zhen Su
Ji-Hui Kang
Xiao-Yan Xie
Xiao-Hua Xie
Bo-Wen Zhuang
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Medical Imaging / Issue 1/2020
Electronic ISSN: 1471-2342
DOI
https://doi.org/10.1186/s12880-020-00447-6

Other articles of this Issue 1/2020

BMC Medical Imaging 1/2020 Go to the issue